Netherlands - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Netherlands Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use grew 3.5% year on year. At 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 1 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria witnessed the worst performance at -14% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 131.70 |
2018 | 126.80 |
2017 | 125.10 |
2016 | 125.60 |
2015 | 117.00 |
Download all data from 2001 to 2019
How does Netherlands rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data |
2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data |
3 |
#3
United Kingdom
|
116 | 2019 | +3.1 % | +3.4 % | View data |
4 |
#4
Iceland
|
110 | 2019 | +2.3 % | +4.8 % | View data |
5 |
#5
Portugal
|
103 | 2019 | +10.5 % | +2.2 % | View data |